Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Privia Health Group, Inc.PRVA · Entity 1532 | Director | June 11, 2024 | June 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Privia Health Group, Inc.
Report date June 11, 2024 · Filed June 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | IndirectSee footnote | 5,773,522 |
Reported balance
After 2024-06-11 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2024-06-11 · Purchase · Acquired 364 · Balance 5,773,522 F1: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2024 Filed Jun 13, 2024 20:05 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | PurchaseCommon Stock, $0.01 par value per share | 364 | $16.50 | $6,006.00 |
DisclosureSEC source: 0001759655-24-000108 · wk-form4_1718309106.xml · nonDerivative · entry 1 Boehler Adam · CIK 0001982325 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,773,522 F1 · shares: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any. F1 · balance_after: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:13 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | PurchaseCommon Stock, $0.01 par value per share | 5,306 | $16.50 | $87,549.00 |
DisclosureSEC source: 0001759655-24-000103 · wk-form4_1717186379.xml · nonDerivative · entry 1 Boehler Adam · CIK 0001982325 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,773,158 F1 · shares: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.48 to $16.50 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F1 · balance_after: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:08 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | PurchaseCommon Stock, $0.01 par value per share | 4,280 | $16.49 | $70,577.20 |
DisclosureSEC source: 0001759655-24-000100 · wk-form4_1717013286.xml · nonDerivative · entry 1 Boehler Adam · CIK 0001982325 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,767,852 F1 · shares: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any. F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.42 to $16.50 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F1 · balance_after: Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any. Read SEC document |
| May 23, 2024 Filed May 23, 2024 21:05 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | PurchaseCommon Stock, $0.01 par value per share | 172,642 | $16.28 | $2,810,611.76 |
DisclosureSEC source: 0001759655-24-000091 · wk-form4_1716498292.xml · nonDerivative · entry 3 Boehler Adam · CIK 0001982325 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,763,572 F1 · shares: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any F1 · balance_after: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:05 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | PurchaseCommon Stock, $0.01 par value per share | 102,229 | $16.43 | $1,679,622.47 |
DisclosureSEC source: 0001759655-24-000091 · wk-form4_1716498292.xml · nonDerivative · entry 2 Boehler Adam · CIK 0001982325 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,590,930 F1 · shares: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any F1 · balance_after: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any Read SEC document |
| May 21, 2024 Filed May 23, 2024 21:05 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | PurchaseCommon Stock, $0.01 par value per share | 277,565 | $16.17 | $4,488,226.05 |
DisclosureSEC source: 0001759655-24-000091 · wk-form4_1716498292.xml · nonDerivative · entry 1 Boehler Adam · CIK 0001982325 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,488,701 F1 · shares: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any F1 · balance_after: Represents shares acquired or held by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.